VioQuest Pharmaceuticals, Inc.
VOQP
$0.00
$0.000.00%
OTC PK
| 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | 06/30/2007 | |
|---|---|---|---|---|---|
| Net Income | 63.30% | -2.04% | -4.78% | -16.56% | 1.83% |
| Total Depreciation and Amortization | 0.00% | -4.17% | 0.00% | 33.33% | -21.74% |
| Total Amortization of Deferred Charges | -100.00% | 121.23% | 12.36% | -- | -- |
| Total Other Non-Cash Items | 87.35% | -71.87% | 229.27% | -172.56% | 226.92% |
| Change in Net Operating Assets | -262.07% | 1,595.86% | -82.35% | -81.87% | 31.40% |
| Cash from Operations | -45.75% | 39.82% | 32.92% | -161.55% | 40.55% |
| Capital Expenditure | -- | -- | 100.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -100.00% | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | 86.86% |
| Cash from Investing | -- | -- | -100.00% | 55,725.81% | 87.98% |
| Total Debt Issued | -- | -- | -100.00% | -76.66% | -- |
| Total Debt Repaid | -- | -- | 100.00% | -558.40% | 66.67% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 186.93% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -49.79% | -- | -- | -- | -- |
| Cash from Financing | 205.94% | -- | -100.00% | -80.42% | 3,696.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 230.82% | 77.92% | -370.90% | -122.15% | 194.39% |